AGMB · Agomab Therapeutics NV
$13.84
-0.44 (-3.08%)
At close · Aug 27
Market Cap
$703.26M
Shares
49.25M
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 4 and 5. Form 3 supplies initial ownership rather than a trade; Form 4 must be filed within two business days of the trade.
No Insider Trading Data
No insider transactions are available for this stock yet.
Key facts
CIK
2020932
CUSIP
00860C102
13F (30d)
30 filings
30 filers
Visit website
Investor relations